Mr. Elliott changed more than 75 percent of the management positions, reduced the company’s workforce by 2,200 employees and paid down more than $2.5 billion in debt. He also stuck a $296 million deal with the U.S. Department of Justice to reduce the company’s exposure to Guidant Corporation’s legal problems. He also developed a clear strategy for the company’s entry into emerging markets.
Related Articles about the Medical Devices Market:
Hospitals, Health Groups Leverage Purchasing Power for Greener Medical Supplies
Prescription Sales Through Primary Healthcare Distributors Reached $268 Billion
Funding Cutbacks, Complex Device Approval Process Threaten Med Tech Industry
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
